<b>Objectives:</b> The objective of this study is to standardize the Bethesda assay for the VWF inhibitors and to estimate the VWD inhibitor titer in two cases of congenital type 3 VWD, which developed the VWF inhibitors. This evidence concerns the gene VWF and von Willebrand disease 3.